Fusion Pharmaceuticals Inc. Annual Net Cash Provided by (Used in) Investing Activities in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
Fusion Pharmaceuticals Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from 2019 to 2023.
  • Fusion Pharmaceuticals Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2024 was -$70.4M, a 187% decline year-over-year.
  • Fusion Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was -$42.8M, a 285% decline from 2022.
  • Fusion Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was $23.1M, a 38.9% decline from 2021.
  • Fusion Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Investing Activities for 2021 was $37.8M.
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$42.8M -$65.9M -285% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-20
2022 $23.1M -$14.7M -38.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-20
2021 $37.8M +$248M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 -$210M -$210M -46052% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-17
2019 -$456K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.